A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study

March 16, 2024 updated by: Slawomir Nowaczyk, Halmstad University

Adaptive Digital Interventions Through Mobile App for Medication Adherence Improvement in Persons With Hypertension: a Pilot Study for Usability

A development and pilot test of an app targeting persons with hypertension. Content in the app was based on persons with hypertensions experiences and a literature review. The participants experience of using the app as well as testing a instrument for medication adherence.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

14

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
      • Halmstad, Sweden
        • Halmstad University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Participants with hypertension, more than one year, were enrolled. From primary care.

Description

Inclusion Criteria:

  • 40-70 years of age,
  • have hypertension (i.e., ICD 10 codes I10-I15 in the person's medical history) for ≥1 year
  • have been prescribed medications to treat said hypertension
  • speak and understand Swedish
  • have a smartphone

Exclusion Criteria:

  • having received medication with unit-dose packages (Apodos)
  • previous stroke
  • previous myocardial infarction
  • psychological disorder or cognitive impairment (i.e. ICD 10 codes F01-F99)
  • pregnancy-induced hypertension´
  • insulin treatment
  • kidney disease, defined as glomerulus filtration rate (GFR) <60 ml/min.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medication adherence
Time Frame: two weeks

Medication adherence measured by the participants self-reported intake of daily medication in the app.

The usage is described in frequencies and response time.
two weeks
Adherence hypertension medication
Time Frame: two weeks

Medication score through the Maastricht Utrecht Adherence in Hypertension (MUAH-16) questionnaire.

The questionnaire consists of four subscales: two of them measures positive and two others measures negative aspects of attitudes to medication adherence and health problem. Min value for each subscale are 4 and maximum 28. Higher value indicate better outcome
two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Halmstad University

Collaborators

Vinnova

Investigators

  • Principal Investigator: Slawomir Nowaczyk, Professor, Halmstad University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2020

Primary Completion (Actual)

February 27, 2021

Study Completion (Actual)

March 1, 2021

Study Registration Dates

First Submitted

December 27, 2023

First Submitted That Met QC Criteria

January 18, 2024

First Posted (Actual)

January 29, 2024

Study Record Updates

Last Update Posted (Actual)

March 19, 2024

Last Update Submitted That Met QC Criteria

March 16, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017_04617

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Only researchers included in the study the will have access.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe